Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clariane SECHIX:CLARIP 61 1-Year Share Buyback Ratio is -0.20 as of Jun. 2026. GuruFocus rates CHIX:CLARIP with a GF Score™ of 61/100 and a GF Value™ of €2.45 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 392 Healthcare Providers & Services companies, Clariane SE ranks better than 66.58% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Clariane SE's current 1-Year Share Buyback Ratio was -0.20%.
CHIX:CLARIp's 1-Year Share Buyback Ratio is ranked better than 66.58% of 392
companies
in the Healthcare Providers & Services industry
Industry Median: -1
vs CHIX:CLARIp: -0.20
Clariane SE (CHIX:CLARIp) 1-Year Share Buyback Ratio Explanation
A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Clariane SE 1-Year Share Buyback Ratio Related Terms
CHIX:CLARIP vs HCA, THC, DVA: 1-Year Share Buyback Ratio Comparison
For the Medical Care Facilities subindustry, Clariane SE's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE 1-Year Share Buyback Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's 1-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Clariane SE's 1-Year Share Buyback Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 1-Year Share Buyback Ratio of -0.20 mean?
Clariane SE (CHIX:CLARIP) has a 1-Year Share Buyback Ratio of -0.20 as of Jun. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Clariane SE and its competitors. According to the industry distribution chart, Clariane SE ranks #131 out of 392 companies in the Healthcare Providers & Services industry, placing it in the top 33.4%.
Is Clariane SE's 1-Year Share Buyback Ratio too high?
Clariane SE's current 1-Year Share Buyback Ratio is -0.20. Based on the distribution chart, Clariane SE ranks #131 out of 392 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's 1-Year Share Buyback Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #131 out of 392 companies for 1-Year Share Buyback Ratio. This puts Clariane SE in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 1-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Clariane SE and its competitors. Clariane SE's current 1-Year Share Buyback Ratio is -0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (CHIX:CLARIP) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.45, compared to a current price of €4.06 — trading 65.7% above its estimated fair value. The current 1-Year Share Buyback Ratio is -0.20. Clariane SE's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For Clariane SE (CHIX:CLARIP), the current 1-Year Share Buyback Ratio is -0.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (CHIX:CLARIP) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.06 is trading 65.7% above its estimated GF Value™ of €2.45.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for CHIX:CLARIP:
1-Year Share Buyback Ratio: -0.20
GF Value™: €2.45 vs. price of €4.06 (65.7% above fair value)
No single metric tells the full story. See the CHIX:CLARIP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score
Get the complete analysis for CHIX:CLARIP
1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:CLARIP has been successfully added to your 
